Mushrooms and the Molecules of Longevity: What the Evidence Really Shows

A newly published review in the journal Discover Aging argues that mushrooms, and one of their signature molecules in particular, deserve a central place in research on healthy aging and longevity. The paper, authored by Kolajo Adedamola Akinyede, Abosede Christianah Ajibare, Samson Olaitan Oselusi and Oluwafemi Omoniyi Oguntibeju, synthesizes decades of work on the nutritional chemistry of fungi and the biological mechanisms by which their compounds appear to slow aging processes in laboratory models. Its central claim is carefully bounded: the strongest evidence comes from cell cultures, yeast, worms, flies and mice, and the authors themselves stress that a substantial gap remains between bench research and clinical application in human populations.

The review opens with the observation that aging is shaped far more by environment than by genes. Citing prior analyses, the authors note that roughly 70 percent of the variation in aging, healthy aging and the risk of age-related disease is attributed to environmental factors, with the genome contributing about 30 percent. Dietary patterns such as the Mediterranean and Okinawan diets, both plant-forward and rich in vitamins, minerals and phytonutrients, are repeatedly associated with longer lifespans in observational research. Mushrooms, the authors argue, fit naturally into this picture because they are neither plants nor animals but members of the fungal kingdom, and they carry a nutritional and pharmacological profile that is difficult to replicate elsewhere in the diet.

That profile is laid out in detail. Mushrooms contain digestible and non-digestible polysaccharides, including chitin, glucans and mannans, whose beta-linked structures underpin prebiotic, immunomodulatory and antitumor activities reported in laboratory studies. Their proteins, including glycated proteins such as lectins from oyster mushrooms and other species, show anticancer, antiviral, antidiabetic and immunostimulatory properties in experimental work. Their lipids include sterols such as ergosterol, which in extracts from reishi has been reported to act as an antioxidant and to reduce cardiovascular risk markers in preclinical settings. Vitamin analyses of edible species report substantial amounts of B vitamins, vitamin C, vitamin E and, notably, vitamin D2, which can be dramatically increased by ultraviolet irradiation of cultivated Agaricus and Pleurotus mushrooms. Mineral content is characterized by high potassium and magnesium and low sodium, a ratio the authors suggest may be favorable for people managing blood pressure.

The industrial backdrop is also striking. Global mushroom production reached approximately 12 million metric tons in 2019, with Asia leading output, and market projections cited in the review anticipate consumption growing from 12.75 million to 20.84 million metric tons between 2018 and 2026, a compound annual growth rate of 6.41 percent. The authors note that controlled indoor cultivation has freed production from temperate climates and made mushrooms available year-round, while also warning that mushrooms grown on unsuitable substrates can accumulate heavy metals, a genuine safety consideration for the industry.

The mechanistic heart of the review is its treatment of the hallmarks of aging. The authors walk through cellular senescence, in which cells irreversibly halt division but remain metabolically active and secrete inflammatory cytokines, growth factors and proteases collectively known as the senescence-associated secretory phenotype. They describe genomic instability, driven in part by oxidative modification of guanine to 8-oxo-guanine, which mispairs with adenine and produces double-stranded breaks in nuclear and mitochondrial DNA. Mitochondrial dysfunction receives particular attention: mitochondrial DNA suffers oxidative damage at an estimated tenfold higher mutation rate than nuclear DNA and has less repair capacity, making it a vulnerable target as reactive oxygen species accumulate. The review also covers inflammaging, the low-grade chronic inflammation driven by immunosenescence and rising levels of interleukin-6 and tumor necrosis factor-alpha, and deregulated nutrient sensing through the insulin and IGF-1, mTOR, sirtuin and AMPK pathways, whose modulation in yeast, worm, fly and mouse models has repeatedly been linked to lifespan extension.

Against this mechanistic canvas, the review positions L-ergothioneine as the standout mushroom-derived compound. Ergothioneine is a water-soluble, thiol-containing amino acid synthesized by fungi but not by plants or animals, meaning humans can obtain it only through diet, chiefly from mushrooms such as Agaricus bisporus, shiitake, oyster mushrooms and maitake. Its cellular uptake relies on a dedicated transporter, OCTN1, which the authors describe as roughly one hundred times more efficient than the transport of most other nutrients. The molecule accumulates in tissues especially vulnerable to oxidative and inflammatory injury, including the brain, blood, bone marrow, eye lens, liver and skin, and it concentrates within mitochondria, where it neutralizes potent oxidants. Compared with glutathione, ergothioneine resists auto-oxidation and, according to studies cited in the review, shows superior scavenging capacity.

Experimental evidence for ergothioneine’s role in aging is drawn from several model systems. When the ergothioneine transporter is knocked out in roundworms and zebrafish, the review reports, oxidative damage increases and longevity decreases, an observation that links the compound directly to lifespan regulation. In cell studies, ergothioneine activates the Nrf2/heme oxygenase-1 pathway and upregulates sirtuin-1 and sirtuin-6, and research from 2020 indicated that it significantly mitigates telomere shortening and reduces the number of short telomeres in cells exposed to oxidative stress. Earlier work also showed that ergothioneine absorbs ultraviolet light in a manner similar to DNA, functioning as a built-in molecular sun shield in skin cells and supporting repair after UV exposure. In the skin, mushroom extracts including those from shiitake, oyster, king oyster, maitake and portabella species have been reported to induce superoxide dismutase and glutathione peroxidase, enzymes that counter oxidative damage, while extracts of Tricholoma matsutake mycelium and Dictyophora indusiata fruiting bodies show anti-wrinkle activity through effects on the metalloproteinases that degrade collagen and elastin.

The nervous system evidence follows a similar pattern. Ergothioneine crosses the blood-brain barrier, and in animal experiments it has halted or ameliorated neurotoxic challenges such as N-methyl-D-aspartate excitotoxicity and cisplatin injury, and prevented the accumulation of beta-amyloid protein that impairs memory and learning in mice. Mechanistically, the review describes how ergothioneine scavenges excess reactive oxygen species, restores redox balance as shown by reduced lipid peroxidation and maintained glutathione ratios, and promotes neuronal differentiation, neurogenesis and neurotrophin signaling through nerve growth factor and brain-derived neurotrophic factor. Observational studies add a correlational layer: cognitively impaired individuals show lower blood levels of ergothioneine than unimpaired individuals, and lower intake is associated with a higher prevalence of brain disorders in the populations studied.

Human epidemiological data, while limited, are highlighted prominently. A study published in 2021, drawing on dietary patterns followed for nearly twenty years among roughly 15,000 Americans, found a 16 percent reduction in mortality risk among mushroom consumers compared with non-consumers, with higher consumption associated with a 35 percent reduction in all-cause mortality. The authors also cite a cross-national comparison in which average daily ergothioneine intake ranged from 1.1 milligrams in the United States to 4.6 milligrams in Italy, with the higher-intake countries showing longer average life expectancy, and a longitudinal metabolomic study in Europe in which baseline ergothioneine levels correlated with decreased cardiovascular disease and reduced mortality over a follow-up period of 21.4 years. These are associations, not proofs of causation, and the review is careful to frame them as signals that justify deeper investigation rather than as clinical endorsements.

The final sections confront the limits of the field squarely. Model organisms such as yeast, roundworms, fruit flies and mice enable fast, inexpensive aging experiments, but they cannot capture every human aging phenotype; yeast, for example, cannot model immunosenescence. Human studies are constrained by ethics, cost, duration and cohort size, and the review warns that translational aging research is vulnerable to misinterpretation and overinterpretation of results. The authors call for integrative approaches that combine metabolomics, proteomics, transcriptomics and genetic and epigenetic data to build standardized protocols for testing mushroom-derived interventions in people. Their conclusion is measured: mushrooms and their components, particularly ergothioneine, are promising dietary allies whose antioxidant and cytoprotective properties delay hallmark aging mechanisms in experimental models, but realizing that promise in human medicine will require the translational work that, for now, remains largely undone.

Subject of Research: A review of the nutritional composition of mushrooms and the anti-aging and longevity effects of mushroom compounds, especially L-ergothioneine, in experimental models and observational human studies.

Article Title: A comprehensive review of the nutritional and therapeutic potential of mushrooms in healthy aging and longevity

Article References: Akinyede, K. A., Ajibare, A. C., Oselusi, S. O., & Oguntibeju, O. O. (2026). A comprehensive review of the nutritional and therapeutic potential of mushrooms in healthy aging and longevity. Discover Aging, 1(1), Article 5. https://doi.org/10.1007/s44518-026-00005-2

Image Credits: AI Generated

DOI: 10.1007/s44518-026-00005-2

Keywords: mushrooms, L-ergothioneine, longevity, healthy aging, oxidative stress, cellular senescence, mitochondrial dysfunction, inflammaging, telomere attrition, nutraceuticals, antioxidants, genomic instability